Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 27, Number 10—October 2021
Dispatch

Rapid Increase in Lymphogranuloma Venereum among HIV-Negative Men Who Have Sex with Men, England, 2019

Mateo Prochazka, Hannah CharlesComments to Author , Hester Allen, Michelle Cole, Gwenda Hughes, and Katy Sinka
Author affiliation: Public Health England, London, UK

Main Article

Table 2

Crude and adjusted incidence rate ratios for lymphogranuloma venereum among men who have sex with men, England, 2019*

Characteristic Crude incidence rate ratio (95% CI) Adjusted† incidence rate ratio (95% CI)
Year
Quarter 1 Referent Referent
Quarter 2 1.10 (0.90–1.35) 1.13 (0.92–1.40)
Quarter 3 1.68 (1.40–2.02) 1.73 (1.43–2.10)
Quarter 4
1.49 (1.24–1.80)
1.66 (1.36–2.01)
HIV
Negative or unknown status Referent Referent
Living with HIV
2.55 (2.26–2.90)
2.23 (1.93–2.57)
Bacterial STI in previous year
No Referent Referent
Yes
4.01 (3.54–4.55)
3.17 (2.77–3.63)
Residence
Rest of England Referent Referent
London
4.28 (3.68–4.98)
3.62 (3.06–4.28)
Region of birth
United Kingdom Referent Referent
Europe 2.42 (2.07–2.82) 1.30 (1.10–1.53)
Asia 1.27 (0.95–1.70) 0.82 (0.61–1.10)
Oceania 2.96 (2.02–4.33) 1.44 (0.98–2.12)
Latin America and Caribbean 3.78 (3.07–4.65) 1.59 (1.27–1.98)
North America 1.89 (1.18–3.02) 1.09 (0.68–1.75)
Africa
1.60 (1.11–2.30)
0.90 (0.62–1.30)
Age group, y
16–24 Referent Referent
25–34 2.16 (1.70–2.75) 1.40 (1.09–1.81)
35–44 2.67 (2.09–3.42) 1.49 (1.14–1.94)
45–54 2.48 (1.91–3.22) 1.47 (1.10–1.96)
55–64 2.00 (1.45–2.76) 1.60 (1.13–2.26)
>65 0.58 (0.27–1.25) 0.55 (0.23–1.28)

*Ratios determined by using generalized linear models using a logarithmic linking function and Poisson distribution with robust variances. †Adjusted for all the covariates shown in the table.

Main Article

Page created: July 30, 2021
Page updated: September 19, 2021
Page reviewed: September 19, 2021
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external